SHUANGCHENG FDA Approval ANDA 210031

ANDA 210031

SHUANGCHENG

FDA Drug Application

Application #210031

Application Sponsors

ANDA 210031SHUANGCHENG

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS250MG/VIAL0BIVALIRUDINBIVALIRUDIN

FDA Submissions

UNKNOWN; ORIG1AP2019-10-23STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

SHUANGCHENG
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210031
            [companyName] => SHUANGCHENG
            [docInserts] => ["",""]
            [products] => [{"drugName":"BIVALIRUDIN","activeIngredients":"BIVALIRUDIN","strength":"250MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/23\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-10-23
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.